GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
522
c/cagrilintide·posted 22 days ago by u/pancreatitis_scare

[Caution] not approved anywhere. keep posts descriptive.

Caution Receipts ×9

co-agonism. That is the whole post, but I will justify it.

Everything else people worry about in c/vendorvetting is downstream of it. Titration speed, muscle cramps, the endless dose arguments — most of it resolves if you sort co-agonism out first, and almost nobody does.

I say this having got it wrong for 15 months. My triglycerides was the thing that eventually made me pay attention, which is a stupid way to learn a lesson that was in the sidebar the whole time.

554 up / 32 down95% upvoted23 commentsid hhixj87 Jul 2026

23 comments

21 in this archive, depth 5

best — the order this archive was captured in

u/viktor_erdogan89 points·22 days ago

Rodent or human data?

replysharereportpermalink
u/yara_mensah22 points·21 days ago

the co-agonism question is real and interesting

replysharereportpermalink
u/viktor_nkemelu74 points·21 days ago

Rodent or human data?

Disagree on that part. 99.2% and 99.3% on the same vial is normal.

replysharereportpermalink
load more comments (1) →
u/zaid_grimaldi52 points·21 days ago

The satiety on amylin analogs is described as physically different. GLP-1 reduces appetite noise, amylin does REDEFINE.

replysharereportpermalink
u/milan_mensah12 points·21 days ago·edited

Rodent or human data?

replysharereportpermalink
u/bpc_scepticresearch peptides18 points·21 days ago

amylin is not a GLP-1, posts conflating them get corrected

replysharereportpermalink
u/rina_sobczak-27 points·21 days ago

Disagree. What you are describing is consistent with CagriSema, not with what you concluded.

replysharereportpermalink
u/georgi_chowdhury1 point·20 days ago

REDEFINE which arm?

replysharereportpermalink
u/runa_grimaldi1 point·21 days ago

long-acting amylin is co-agonism, different satiety profile

replysharereportpermalink
u/hedda_aguirre1 point·20 days ago

not approved anywhere, keep posts descriptive, not instructional

replysharereportpermalink
u/sequence_checkerresearch peptides1 point·20 days ago

amylin receptor distribution is different from GLP-1

replysharereportpermalink
u/hugo_pires1 point·20 days ago

the amylin agonist pool is small, community is satiety

replysharereportpermalink
u/controversial_only27 points·21 days ago

Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.

replysharereportpermalink
u/pancreatitis_scareOP39 points·21 days ago

amylin is not a GLP-1, posts conflating them get corrected

replysharereportpermalink
u/ravi_sandvik18 points·21 days ago

research use only, no human protocols in posts

replysharereportpermalink
u/pancreatitis_scareOP11 points·20 days ago

The research community is small on cagrilintide. Forum lore changes faster than data.

replysharereportpermalink
u/lukas_vermeulen14 points·21 days ago

Not convinced. The evidence does not support that reading.

replysharereportpermalink
u/pancreatitis_scareOP9 points·20 days ago

CagriSema is a fixed combo in trials, not user-mixed

replysharereportpermalink
u/nl_verzekering5 points·20 days ago

the mechanism is different, the side effect profile reflects it

replysharereportpermalink
u/ledger_modMOD17 points·21 days ago

Tracking number removed. It identifies both ends of a shipment.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/cagrilintide

Amylin analog pharmacology and the CagriSema combination: why amylin and GLP-1 co-agonism produces a different satiety profile, the REDEFINE readouts, and the very limited pool of people handling cagrilintide as research material.

19kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/cagrilintide rules
  1. Amylin is not a GLP-1. Posts conflating them get corrected.
  2. CagriSema ratios in trials are fixed-dose. Do not extrapolate to self-mixing.
  3. Not approved anywhere. Keep posts descriptive, not instructional.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.